IL-17
Selected indexed studies
- The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond. (Front Immunol, 2018) [PMID:30127781]
- IL-17 for therapy. (J Dermatol Sci, 2017) [PMID:28633806]
- The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases. (Int Immunopharmacol, 2022) [PMID:34863654]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond. (2018) pubmed
- IL-17 for therapy. (2017) pubmed
- The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases. (2022) pubmed
- Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability. (2015) pubmed
- IL-17 in the immunopathogenesis of spondyloarthritis. (2018) pubmed
- IL-17 inhibitors in axial spondyloarthritis. An overview. (2024) pubmed
- The Role of IL-17 in Systemic Autoinflammatory Diseases: Mechanisms and Therapeutic Perspectives. (2025) pubmed
- IL-17 promotes osteoclast-induced bone loss by regulating glutamine-dependent energy metabolism. (2024) pubmed
- From IL-17 to IFN-γ in inflammatory skin disorders: Is transdifferentiation a potential treatment target? (2022) pubmed
- IL-17 and colorectal cancer: From carcinogenesis to treatment. (2019) pubmed